and their 20-years of work toward development of a vaccine that began with the isolation of the cancer-causing HPVs; Details about cervical cancer and death rate in women around the world; Description of the five HPVs found to be responsible for most cervical cancers; Implications of the ...
Human papillomavirus vaccine: the beginning of the end for cervical cancer. Isr Med Assoc J 2007; 9 :156-8.Leggatt, G. R., and I. H. Frazer. 2007. HPV vaccines: the beginning of the end for cervical cancer. Curr. Opin. Immunol. 19:232-238....
MSI picks out rate elevates along with the cervix of the uterus pathological change degree ascension, FHIT gene MSI in CIN is the later period event; In cervical cancer MSI elevates along with the clinical by stages ascension, is cervical cancer malignancy progresses the early event.[translate]...
Two such vaccines have recently been shown to prevent persistent HPV infection and associated cervical cancer precursor lesions. The genotype-specific neutralising antibody directed at conformational epitopes of the L1 major capsid protein is likely to mediate protection. Vaccines therapeutic for persisting ...
The beginning of the end for cervical cancer? Editorial. Discusses the development of an effective vaccine for cervical human papillomavirus (HPV). Description of Koutsky et al. and their 20-years of w... Crum,P Christopher - 《New England Journal of Medicine》 被引量: 135发表: 2002年 HPV...
The situation of cervical cancer prevention in South-East Europe is hardly documented, in spite of the fact that it encloses the most affected countries of Europe. We estimated the number of cases of cervical cancer, the number of deaths from this malignancy and the corresponding rates for 11...
(spring and autumn) and two symposiums/workshops annually. In its initial stages, KGOG comprised the president, research committee, and operating committee, with advisory subcommittees for cervical cancer, ovarian cancer, endometrial cancer, pathology, radiation therapy, medical oncology, and ...